Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
Mem. Inst. Oswaldo Cruz
;
117: e210395, 2022.
Article
Dans Anglais
|
LILACS-Express
| LILACS
| ID: biblio-1360602
ABSTRACT
Transforming growth factor beta (TGF-β) is deeply involved on the pathogenesis of Chagas disease. Our group has been investigating the participation of this pleiotropic cytokine in different aspects of Chagas disease over the last 20 years. Important observations have been made, such as (i) the ability of Trypanosoma cruzi in activating latent TGF-β; (ii) the potential involvement of TGF-β pathway on T. cruzi invasion of host cells; (iii) association of TGF-β with parasite intracellular replication; (iv) cardiac fibrosis development and maintenance; (v) disruption of Connexin-43 plaque structures and (vi) inflammation and immune response. In this perspective article we intend to discuss the advances of the potential use of new therapies targeting TGF-β to treat the cardiac alterations of Chagas disease-affected patients.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
langue:
Anglais
Texte intégral:
Mem. Inst. Oswaldo Cruz
Thème du journal:
Médecine tropicale
/
Parasitologie
Année:
2022
Type:
Article
Pays d'affiliation:
Brésil
/
France
Institution/Pays d'affiliation:
Fundação Oswaldo Cruz-Fiocruz/BR
/
Institut National de la Santé et de la Recherche Médicale/FR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS